Pancreatic Cancer Research

ResearcherIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Active in the last 2 years

Crescenzo D’Alterio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0275-3367; OpenAlex author ID A5000562109. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Targeting the Tumor-Stroma Crosstalk: An AI-Based Virtual Screening Strategy for Dual MET/SMO Inhibitors in Pancreatic Cancer Co-author DOI 10.64898/2026.07.03.736313↗
  2. CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients. Co-author DOI 10.3390/cells11213340↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefania Scala · 2 shared papers, 2022–2026 · strength 0.37
  2. Rosaria Benedetti · 1 shared paper, 2026 · strength 0.24
  3. Fortunato Ciardiello · 1 shared paper, 2026 · strength 0.24
  4. Sandro Cosconati · 1 shared paper, 2026 · strength 0.24
  5. Floriana Morgillo · 1 shared paper, 2026 · strength 0.24
  6. Ugo Chianese · 1 shared paper, 2026 · strength 0.24
  7. Michele Roggia · 1 shared paper, 2026 · strength 0.24
  8. Alessandro Giardino · 1 shared paper, 2022 · strength 0.13
  9. Isabella M. Frigerio · 1 shared paper, 2022 · strength 0.13
  10. Ferdinando De Vita · 1 shared paper, 2022 · strength 0.13
  11. Giovanni Butturini · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.